Junto Magazine Category
Biotech & Digital Health
8 articles
-
AI governance for space biotech: risks, funding and operational steps
For a space biotech these practices must integrate biosafety. L'artificial intelligence enters today into laboratories and orbits and asks to be governed.
-
The New Paradigm of Investment Standards in Life Sciences
Alchemab raised a record €29.3 million of public money for its AI antibody platform, resetting what European investors expect from deep tech biotech deals.
-
Wearable Robotics closes €5M Series A and accelerates expansion
Wearable robotics for rehabilitation: Wearable Robotics raises €5M to expand products, markets and regulatory compliance globally.
-
Cellular Expansion Platform: Scinus Raises €3 Million for Osilaris
Scinus secures €3M for the Osilaris cellular expansion platform, aiming at commercial rollout and production of cell therapies.
-
Gene editing for tropical crops: Tropic closes €91.3M and brings gene-edited bananas to market
Tropic closes a €91.3M round to bring gene-edited bananas and rice to market, accelerate production, and strengthen supply chains.
-
Digital Health Eindhoven AI: Catharina Hospital and the AI Centre of Excellence
AI in healthcare in Eindhoven: Catharina Hospital, the AI Centre of Excellence, privacy, ethics, and Brainport driving innovation.
-
ECM therapies funding: Engitix closes €21 million extension for cancer and fibrosis
Engitix closes €21 million to extend targeted ECM therapies, expanding its pipeline, ECM data, and biotech partnerships.
-
Spore.Bio: AI for Microbiological Science and Biotech Diagnostics
Spore.Bio secures Google.org funding for AI in microbiology and launches Spore.Labs, a research division for rapid diagnostics.